The Food and Drug Administration has approved the first pill to treat multiple sclerosis.
Gilenya helps reduce MS relapses.
The new drug comes with possible side effects, including the risk of sudden heart irregularities.
Patients are advised to take their first dose under a doctor's supervision.
Until now, injections were the only treatment option for MS patients.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.